Related Experiment Video
Updated: Feb 25, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
PREVALENCE OF MICROALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETES MELLITUS.
J S Saini1, A S Narula2, S Naqvi3
1Sr Adviser (Med & Endocrinology) Command Hospital (SC), Pune.
Microalbuminuria affects 40% of patients with non-insulin dependent diabetes mellitus. Higher risk is linked to longer diabetes duration, poor glycemic control, and elevated systolic blood pressure.
Area of Science:
- Nephrology
- Endocrinology
- Diabetology
Background:
- Non-insulin dependent diabetes mellitus (NIDDM) is a global health concern.
- Microalbuminuria is an early indicator of diabetic nephropathy.
- Early detection and management of microalbuminuria can prevent kidney disease progression.
Purpose of the Study:
- To determine the prevalence of microalbuminuria in NIDDM patients.
- To identify risk factors associated with microalbuminuria in this population.
Main Methods:
- Cross-sectional study involving 50 NIDDM patients.
- Assessment of microalbuminuria prevalence.
- Analysis of patient demographics, diabetes duration, glycemic control, and blood pressure.
Main Results:
- The prevalence of microalbuminuria was 40% (20 out of 50 patients).
- Microalbuminuria was significantly associated with longer diabetes duration (>5 years).
- Poor glycemic control and higher systolic blood pressure were also linked to increased microalbuminuria prevalence.
Conclusions:
- Microalbuminuria is prevalent in NIDDM patients.
- Diabetes duration, glycemic control, and systolic blood pressure are key factors associated with microalbuminuria.
- Screening for microalbuminuria is crucial in NIDDM management to prevent diabetic nephropathy.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Dipeptidyl Peptidase 4 Inhibitors

